364 related articles for article (PubMed ID: 10326954)
1. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
Maus TL; Nau C; Brubaker RF
Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
[TBL] [Abstract][Full Text] [Related]
2. Assessment of ocular hypotensive mechanisms and additivity of antiglaucoma drugs in humans.
Kaufman PF
Arch Ophthalmol; 1999 May; 117(5):673-4. PubMed ID: 10326968
[No Abstract] [Full Text] [Related]
3. Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.
Larsson LI
Arch Ophthalmol; 2001 Apr; 119(4):492-5. PubMed ID: 11296014
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans.
Schadlu R; Maus TL; Nau CB; Brubaker RF
Arch Ophthalmol; 1998 Nov; 116(11):1441-4. PubMed ID: 9823343
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the ocular hypotensive effect of brimonidine, dorzolamide, latanoprost, or artificial tears added to timolol in glaucomatous monkey eyes.
Wang RF; Serle JB; Gagliuso DJ; Podos SM
J Glaucoma; 2000 Dec; 9(6):458-62. PubMed ID: 11131752
[TBL] [Abstract][Full Text] [Related]
6. Effects of brimonidine on aqueous humor dynamics in human eyes.
Toris CB; Gleason ML; Camras CB; Yablonski ME
Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure.
Yüksel N; Karabaş L; Altintaş O; Yildirim Y; Cağlar Y
Ophthalmologica; 2002; 216(1):45-9. PubMed ID: 11901288
[TBL] [Abstract][Full Text] [Related]
8. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
[TBL] [Abstract][Full Text] [Related]
9. Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination.
Tsukamoto H; Larsson LI
Arch Ophthalmol; 2004 Feb; 122(2):190-3. PubMed ID: 14769595
[TBL] [Abstract][Full Text] [Related]
10. Ultrabiomicroscopic study of the effects of brimonidine, apraclonidine, latanoprost and ibopamine on the chamber angle and ciliary body.
Lo Presti L; Morgese A; Ravot M; Brogliatti B; Boles Carenini B
Acta Ophthalmol Scand Suppl; 1998; (227):32-4. PubMed ID: 9972336
[TBL] [Abstract][Full Text] [Related]
11. Effects of apraclonidine on aqueous humor dynamics in human eyes.
Toris CB; Tafoya ME; Camras CB; Yablonski ME
Ophthalmology; 1995 Mar; 102(3):456-61. PubMed ID: 7891985
[TBL] [Abstract][Full Text] [Related]
12. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P
Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241
[TBL] [Abstract][Full Text] [Related]
13. The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine.
Nordlund JR; Pasquale LR; Robin AL; Rudikoff MT; Ordman J; Chen KS; Walt J
Arch Ophthalmol; 1995 Jan; 113(1):77-83. PubMed ID: 7826297
[TBL] [Abstract][Full Text] [Related]
14. Apraclonidine and timolol. Combined effects in previously untreated normal subjects.
Koskela T; Brubaker RF
Arch Ophthalmol; 1991 Jun; 109(6):804-6. PubMed ID: 1675048
[TBL] [Abstract][Full Text] [Related]
15. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
Chen TC; Ang RT; Grosskreutz CL; Pasquale LR; Fan JT
Ophthalmology; 2001 Jun; 108(6):1033-8. PubMed ID: 11382625
[TBL] [Abstract][Full Text] [Related]
16. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
Yuen NS; Cheung P; Hui SP
Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723
[TBL] [Abstract][Full Text] [Related]
17. Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.
Sponsel WE; Paris G; Trigo Y; Pena M; Weber A; Sanford K; McKinnon S
Am J Ophthalmol; 2002 Jan; 133(1):11-8. PubMed ID: 11755835
[TBL] [Abstract][Full Text] [Related]
18. A comparative study on the effects of apraclonidine and timolol on the ophthalmic blood flow velocity waveforms.
Oruç S; Sener EC
Int Ophthalmol; 1999; 23(2):69-73. PubMed ID: 11196122
[TBL] [Abstract][Full Text] [Related]
19. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.
Gabelt BT; Robinson JC; Hubbard WC; Peterson CM; Debink N; Wadhwa A; Kaufman PL
Exp Eye Res; 1994 Dec; 59(6):633-44. PubMed ID: 7698258
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]